DUBLIN, May 1, 2024 /PRNewswire/ -- Jazz Pharmaceuticals
plc (Nasdaq: JAZZ) today announced that Company management will
participate in the BofA Securities 2024 Global Health Care
Conference on Wednesday, May 15,
2024, in Las Vegas. The
fireside chat will be held at 10:00 a.m.
PT / 1:00 p.m. ET /
6:00 p.m. IST.
An audio webcast of the fireside chat will be available via the
Investors section of the Jazz Pharmaceuticals website at
https://investor.jazzpharma.com/investors/events-presentations. A
replay of the webcast will be archived on the website for 30
days.
About Jazz Pharmaceuticals
Jazz
Pharmaceuticals plc (Nasdaq: JAZZ) is a global biopharma
company whose purpose is to innovate to transform the lives of
patients and their families. We are dedicated to developing
life-changing medicines for people with serious diseases — often
with limited or no therapeutic options. We have a diverse portfolio
of marketed medicines, including leading therapies for sleep
disorders and epilepsy, and a growing portfolio of cancer
treatments. Our patient-focused and science-driven approach powers
pioneering research and development advancements across our robust
pipeline of innovative therapeutics in oncology and neuroscience.
Jazz is headquartered in Dublin, Ireland with research
and development laboratories, manufacturing facilities and
employees in multiple countries committed to serving patients
worldwide. Please visit www.jazzpharmaceuticals.com for
more information.
Contacts:
Investors:
Andrea N. Flynn, Ph.D.
Vice President, Head, Investor Relations
Jazz Pharmaceuticals plc
InvestorInfo@jazzpharma.com
Ireland +353 1 634 3211
U.S. +1 650 496 2717
Media:
Kristin
Bhavnani
Head of Global Corporate Communications
Jazz Pharmaceuticals plc
CorporateAffairsMediaInfo@jazzpharma.com
Ireland +353 1 637 2141
U.S. +1 215 867 4948
Logo -
https://mma.prnewswire.com/media/272253/Jazz_Pharmaceuticals_New_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/jazz-pharmaceuticals-to-participate-in-the-bofa-securities-2024-health-care-conference-302132372.html